Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I.N. Belaconi, C.L. Toma, S. Dumitrache-Rujinski, C. Tudose, D. Leonte, M.A. Bogdan (Bucharest, Romania). Challenges in the management of patients with ANCA- associated vasculitides. Eur Respir J 2012; 40: Suppl. 56, 2376

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary vasculitis: update on the management of ANCA-associated vasculitis Source: Eur Respir Mon; 2009: 46: 251–264 Year: 2009 Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020 Pulmonary disorders in patients with polymyositis and dermatomyositis Source: Eur Respir J 2001; 18: Suppl. 33, 511s Year: 2001 Pulmonary manifestations of systemic vasculitis in childhood Source: Breathe, 16 (4) 200211; 10.1183/20734735.0211-2020 Year: 2020 Rituximab in the management of idiopathic inflammatory myopathies complicated by interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 ANCA associated vasculitis – Evaluation of diagnosis, treatment and outcome in a group of 68 patients Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Pulmonary manifestations of myeloperoxidase-antineutrophil cytoplasmic antibody(MPO-ANCA)-related systemic vasculitis:CT findings in 50 patients Source: Eur Respir J 2002; 20: Suppl. 38, 267s Year: 2002 Pulmonary manifestations in Iranian patients with chronic granulomatosis disorder Source: Eur Respir J 2007; 30: Suppl. 51, 86s Year: 2007 Autoantibodies to the surfactant protein D in patients with interstitial lung diseases associated with amyopathic dermatomyositis and systemic sclerosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Multidisciplinary approach to systemic diseases: benefits for diagnosis and management of complex disorders Source: Eur Respir Monogr 2019; 86: 1-13 Year: 2019 Evidence-based consensus recommendations for the identification and management of interstitial lung disease in systemic sclerosis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry Source: Eur Respir J 2015; 46: 186-196 Year: 2015 Management of ANCA-associated vasculitis (AAV): A single-centre perspective from respiratory clinic. Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Pulmonary manifestations in adult patients with chronic granulomatous disease Source: Eur Respir J 2015; 45: 1613-1623 Year: 2015 Respiratory manifestations in patients with systemic vasculitis with renal involvement in a tertiary hospital Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018 Management and prognosis of respiratory manifestations revealing systemic lupus erythematosus Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Pulmonary involvement in rheumatological diseases in children Source: Virtual Congress 2021 – Paediatric bronchology Year: 2021 Pulmonary manifestations in patients with IgG4-related disease at a tertiary care institute Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015